Evidence map›Paper›PMID 33552876›Full record

ArticleJournal of kidney cancer and VHL2021

Epidemiology and Clinicopathological Profile of Renal Cell Carcinoma: A Review from Tertiary Care Referral Centre.

Likhiteswer Pallagani, Gautam Ram Choudhary, Pandey Himanshu, Vijay K S Madduri, Mahendra Singh, Prateek Gupta, Nikita Shrivastava, Gaurav Baid, Rao Meenakshi, Nalwa Aasma and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of kidney cancer and VHL, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Abscopal Effect Demonstrated on [18F]FDG PET/CT in a Case of Renal Cell Carcinoma Postnephrectomy.Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Likhiteswer PallaganiDepartment of Urology, All India Institute of Medical Sciences, Jodhpur, India.
Gautam Ram ChoudharyDepartment of Urology, All India Institute of Medical Sciences, Jodhpur, India.
Pandey HimanshuDepartment of Urology, All India Institute of Medical Sciences, Jodhpur, India.
Vijay K S MadduriDepartment of Urology, All India Institute of Medical Sciences, Jodhpur, India.
Mahendra SinghDepartment of Urology, All India Institute of Medical Sciences, Jodhpur, India.
Prateek GuptaDepartment of Urology, All India Institute of Medical Sciences, Jodhpur, India.
Nikita ShrivastavaDepartment of Urology, All India Institute of Medical Sciences, Jodhpur, India.
Gaurav BaidDepartment of Urology, All India Institute of Medical Sciences, Jodhpur, India.
Rao MeenakshiDepartment of Pathology, All India Institute of Medical Sciences, Jodhpur, India.
Nalwa AasmaDepartment of Pathology, All India Institute of Medical Sciences, Jodhpur, India.
Puneet PareekDepartment of Surgical Oncology, All India Institute of Medical Sciences, Jodhpur, India.
Misra SanjeevDepartment of Radio-Therapy, All India Institute of Medical Sciences, Jodhpur, India.
All India Institute of Medical Sciences Jodhpur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) accounts for 3% of all adult cancers and 85% of all kidney tumours. Incidence of RCC is lower in Asian region, particularly in India, probably due to lack of reporting. Most of the data about RCC are from Western countries; and data from India are scarce, especially regarding para-neoplastic syndromes. We sought to determine the epidemiology, clinicopathological profile and management of RCC in a tertiary care centre in Western India. This was a retrospective study that involved data analysis of records of RCC patients who presented to our institution from April 2016 to February 2020. Laboratory investigations, including tests for paraneoplastic syndrome (PNS), and relevant radiologic investigations were performed and treatment was offered according to the stage, patient factors and available modalities. A total 142 RCC patients were included in the study. The median age of presentation was 58 years. Most of the patients (67%) were symptomatic, and 33% of the patients were asymptomatic, and the RCC was diagnosed incidentally. A large number of patients (56.3%) had PNS. The most common histopathologic type of RCC was clear cell carcinoma (68.8%), followed by papillary (20%) and chromophobe (8%) carcinoma. 40% of carcinomas with sarcomatoid differentiation were seen in patients under 50 years of age. Two cases of multicystic RCC were both seen in patients less than 50 years of age. 65.5% of the patients presented at Stage 1 and 2. Most surgeries (71.2%) were done in a minimally invasive manner. A significant number of patients were asymptomatic, in which RCC was detected incidentally. The age of presentation was earlier, yet the patients had a higher tumour stage. More than half of the patients had PNSs. Despite growing trend towards Western data, the significantly higher number of patients with PNSs and early age of presentation suggest inherent differences in tumour biology, possibly related to differences in genetic and environmental factors.

Indexed as

epidemiologylaparoscopyminimally invasive surgeryparaneoplastic syndromesrenal cell carcinomarobotic surgeryWestern India

Identifiers

PMID33552876
PMCPMC7827726
OpenAlexW3122800506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.